{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:44Z","timestamp":1790704364767,"version":"4.1.0"},"reference-count":54,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Autism Transitions Research Project","award":["UJ2MC31073"],"award-info":[{"award-number":["UJ2MC31073"]}]},{"name":"Autism Transitions Research Project","award":["UT6MC45902"],"award-info":[{"award-number":["UT6MC45902"]}]},{"name":"Alternative Approaches to Supporting ASD Services for Young Adults","award":["5R01MH117653"],"award-info":[{"award-number":["5R01MH117653"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Autism"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>\n                    Recent research has suggested that people with autism spectrum disorder may be disproportionately at risk of substance use disorders. This study analyzed national-level Medicaid Claims data to compare substance use disorder prevalence among Medicaid enrollees with autism spectrum disorder (\n                    <jats:italic>N<\/jats:italic>\n                    \u2009=\u2009388,426) and a random sample of enrollees without autism spectrum disorder (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009745,699) and to examine whether this association differs across sex and age groups and changes after adjusting for co-occurring mental health conditions. We also examined how the association between autism spectrum disorder and substance use disorder is moderated by co-occurring non-autism spectrum disorder mental health conditions and by community-level social determinants of health by merging Medicaid Claims data with zip code-level US Census data on socioeconomic deprivation. By 2016, 7% of Medicaid beneficiaries with autism spectrum disorder and no intellectual disability had at least one substance use disorder diagnosis, up from 1.75% USD prevalence among enrollees with autism spectrum disorder (no intellectual disability) in 2012 Medicaid data. Individuals with autism spectrum disorder aged 30\u201364\u2009years were at an elevated risk of cannabis and hallucinogen disorders; this risk is likely compounded by co-occurring mental health conditions, which affect a half of all individuals with autism spectrum disorder and only 23% of individuals without autism spectrum disorder. Research and policy implications are discussed in turn.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Lay abstract<\/jats:title>\n                    <jats:p>Recent research has suggested that people with autism spectrum disorder may be disproportionately at risk of substance use disorders. The present study analyzed national-level Medicaid Claims data to compare substance use disorder prevalence among Medicaid beneficiaries with autism spectrum disorder and without autism spectrum disorder and to examine whether this association differs across sex and age groups and depends on mental health conditions besides autism. We also examined how the association between autism spectrum disorder and substance use disorder is moderated by co-occurring non-autism spectrum disorder mental health conditions and by community-level social determinants of health. For the latter purpose, Medicaid Claims data were merged with zip code-level US Census data on socioeconomic deprivation. Our analyses demonstrated that, by 2016, 7% of Medicaid enrollees with autism spectrum disorder and no intellectual disability had at least one substance use disorder diagnosis, up from 1.75% USD prevalence among enrollees with autism spectrum disorder (no intellectual disability) in 2012 Medicaid data. Individuals with autism spectrum disorder aged 30\u201364\u2009years are at an elevated risk of cannabis and hallucinogen use disorders, while this risk is likely compounded by co-occurring mental health conditions, which affect a half of all individuals with autism spectrum disorder and only 23% of individuals without autism spectrum disorder. Research and policy implications are discussed in turn.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/13623613251325282","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T23:21:58Z","timestamp":1743290518000},"page":"1674-1687","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparing the prevalence of substance use disorders between persons with and without autism spectrum disorders"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4225-9742","authenticated-orcid":false,"given":"Victor","family":"Lushin","sequence":"first","affiliation":[{"name":"National Institutes of Health, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Marcus","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Tao","sequence":"additional","affiliation":[{"name":"Drexel University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malitta","family":"Engstrom","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7758-4708","authenticated-orcid":false,"given":"Anne","family":"Roux","sequence":"additional","affiliation":[{"name":"Drexel University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0610-0355","authenticated-orcid":false,"given":"Lindsay","family":"Shea","sequence":"additional","affiliation":[{"name":"Drexel University, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-022-01238-1"},{"key":"e_1_3_2_3_1","author":"Agency for Healthcare Research and Quality","year":"2016","unstructured":"Agency for Healthcare Research and Quality. (2016). Healthcare Cost and Utilization Project (HCUP). HCUP clinical classifications software (CCS) for ICD-9-CM.","journal-title":"Healthcare Cost and Utilization Project (HCUP). HCUP clinical classifications software (CCS) for ICD-9-CM"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2010.10.023"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","unstructured":"Anderson S. A. Catallozzi M. (2021). Autism spectrum disorder and the risk of substance use disorder: A call for targeted screening and prevention in adolescents. JAMA Pediatrics 4 Article e205376. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.5376","DOI":"10.1001\/jamapediatrics.2020.5376"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.4137\/SART.S39921"},{"key":"e_1_3_2_7_1","volume-title":"ACO benchmarks based on area deprivation index mask inequities","author":"Azar K. M.","year":"2023","unstructured":"Azar K. M., Alexander M., Smits K., Tio A., deGhetaldi L. (2023). ACO benchmarks based on area deprivation index mask inequities. Health Affairs Forefront."},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","unstructured":"Baranyi G. Fazel S. Langerfeldt S. D. Mundt A. P. (2022). The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: A systematic review and meta-analysis. The Lancet Public Health 7(6) e557\u2013e568. https:\/\/doi.org\/10.1016\/S2468-2667(22)00093-7","DOI":"10.1016\/S2468-2667(22)00093-7"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1050(199805)7:3<229::AID-HEC315>3.0.CO;2-R"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","unstructured":"Butwicka A. L\u00e5ngstr\u00f6m N. Larsson H. Lundstr\u00f6m S. Serlachius E. Almqvist C. Fris\u00e9n L. Lichtenstein P. (2017). Increased risk for substance use-related problems in autism spectrum disorders: A population-based cohort study. Journal of Autism and Developmental Disorders 47(1) 80\u201389. https:\/\/doi.org\/10.1007\/s10803-016-2914-2","DOI":"10.1007\/s10803-016-2914-2"},{"key":"e_1_3_2_11_1","unstructured":"Chronic Conditions Data Warehouse. (2023). https:\/\/www2.ccwdata.org"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1176\/ps.2009.60.1.35"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","unstructured":"Clarke T. Tickle A. Gillott A. (2016). Substance use disorder in Asperger syndrome: An investigation into the development and maintenance of substance use disorder by individuals with a diagnosis of Asperger syndrome. International Journal of Drug Policy 27 154\u2013163. https:\/\/doi.org\/10.1016\/j.drugpo.2015.06.003","DOI":"10.1016\/j.drugpo.2015.06.003"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"De Alwis D. Agrawal A. Reiersen A. M. Constantino J. N. Henders A. Martin N. G. Lynskey M. T. (2014). ADHD symptoms autistic traits and substance use and misuse in adult Australian twins. Journal of Studies on Alcohol and Drugs 75(2) 211\u2013221. https:\/\/doi.org\/10.15288\/jsad.2014.75.211","DOI":"10.15288\/jsad.2014.75.211"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-015-1730-1"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033351"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/1744629505049730"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40489-021-00242-1"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","unstructured":"Helverschou S. B. Brunvold A. R. Arnevik E. A. (2019). Treating patients with co-occurring autism spectrum disorder and substance use disorder: A clinical explorative study. Substance Abuse 13 1178221819843291. https:\/\/doi.org\/10.1177\/1178221819843291","DOI":"10.1177\/1178221819843291"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/1062860617753063"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","unstructured":"Huang J. S. Yang F. C. Chien W. C. Yeh T. C. Chung C. H. Tsai C. K. Tsai S. J. Yang S. S. Tzeng N. S. Chen M. H. Liang C. S. (2021). Risk of substance use disorder and its associations with comorbidities and psychotropic agents in patients with autism. JAMA Pediatrics 175 Article e205371. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.5371","DOI":"10.1001\/jamapediatrics.2020.5371"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","unstructured":"Isenberg B. M. Yule A. M. McKowen J. W. Nowinski L. A. Forchelli G. A. Wilens T. E. (2019). Considerations for treating young people with comorbid autism spectrum disorder and substance use disorder. Journal of the American Academy of Child & Adolescent Psychiatry 58(12) 1139\u20131141. https:\/\/doi.org\/10.1016\/j.jaac.2019.08.467","DOI":"10.1016\/j.jaac.2019.08.467"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.4135\/9781412984522"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","unstructured":"Kronenberg L. M. Slager-Visscher K. Goossens P. J. J. van den Brink W. van Achterberg T. (2014). Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit\/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): A patient\u2019s perspective. BMC Psychiatry 14 1\u20139. https:\/\/doi.org\/10.1186\/s12888-014-0264-1","DOI":"10.1186\/s12888-014-0264-1"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","unstructured":"Kronenberg L. M. Verkerk-Tamminga R. Goossens P. J. van den Brink W. van Achterberg T. (2015). Personal recovery in individuals diagnosed with substance use disorder (SUD) and co-occurring attention deficit\/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Archives of Psychiatric Nursing 29(4) 242\u2013248. https:\/\/doi.org\/10.1016\/j.apnu.2015.04.006","DOI":"10.1016\/j.apnu.2015.04.006"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","unstructured":"Lai M. C. Kassee C. Besney R. Bonato S. Hull L. Mandy W. Szatmari P. Ameis S. H. (2019). Prevalence of co-occurring mental health diagnoses in the autism population: A systematic review and meta-analysis. The Lancet Psychiatry 6(10) 819\u2013829. https:\/\/doi.org\/10.1016\/s2215-0366(19)30289-5","DOI":"10.1016\/S2215-0366(19)30289-5"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/aur.3007"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2024.209484"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.adolescence.2014.08.007"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","unstructured":"Masin-Moyer M. Kim J. C. Engstrom M. Solomon P. (2022). A scoping review of the Trauma Recovery and Empowerment Model (TREM). Trauma Violence & Abuse 23 699\u2013715. https:\/\/doi.org\/10.1177\/1524838020967862","DOI":"10.1177\/1524838020967862"},{"key":"e_1_3_2_31_1","unstructured":"Medicaid and CHIP Payment and Access Commission. (2023). Behavioral health benefits. An overview. https:\/\/www.macpac.gov\/subtopic\/behavioral-health-benefits\/"},{"key":"e_1_3_2_32_1","unstructured":"Neighborhood Atlas. (2023). https:\/\/www.neighborhoodatlas.medicine.wisc.edu"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108555"},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","unstructured":"Orsmond G. I. Shattuck P. T. Cooper B. P. Sterzing P. R. Anderson K. A. (2013). Social participation among young adults with an autism spectrum disorder. Journal of Autism and Developmental Disorders 43(11) 2710\u20132719. https:\/\/doi.org\/10.1007\/s10803-013-1833-8","DOI":"10.1007\/s10803-013-1833-8"},{"key":"e_1_3_2_35_1","unstructured":"Palle S. (2023). Rethinking the area deprivation index: A call for more effective measures to promote health equity. https:\/\/www.healthcaredive.com\/news\/rethinking-area-deprivation-index-effective-measures-health-equity-Srilekha-Palle\/650038\/?utm_medium=email&utm_source=rasa_io&utm_campaign%20=newsletter"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13033-016-0060-z"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.0266"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.1465"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.07.022"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","unstructured":"Ressel M. Thompson B. Poulin M.-H. Normand C. L. Fisher M. H. Couture G. Iarocci G. (2020). Systematic review of risk and protective factors associated with substance use and abuse in individuals with autism spectrum disorders. Autism 24(4) 899\u2013918. https:\/\/doi.org\/10.1177\/1362361320910963","DOI":"10.1177\/1362361320910963"},{"key":"e_1_3_2_41_1","doi-asserted-by":"crossref","unstructured":"Rigles B. (2017). The relationship between adverse childhood events resiliency and health among children with autism. Journal of Autism and Developmental Disorders 47(1) 187\u2013202. https:\/\/doi.org\/10.1007\/s10803-016-2905-3","DOI":"10.1007\/s10803-016-2905-3"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dhjo.2022.101289"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-005-0517-0"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2016.1170146"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.13671"},{"key":"e_1_3_2_46_1","doi-asserted-by":"crossref","unstructured":"Sheidow A. J. McCart M. Zajac K. Davis M. (2012). Prevalence and impact of substance use among emerging adults with serious mental health conditions. Psychiatric Rehabilitation Journal 35(3) 235\u2013243. https:\/\/doi.org\/10.2975\/35.3.2012.235.243","DOI":"10.2975\/35.3.2012.235.243"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08649-0"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.12.012"},{"key":"e_1_3_2_49_1","author":"Substance Abuse and Mental Health Services Administration","year":"2020","unstructured":"Substance Abuse and Mental Health Services Administration. (2020). TIP 42: Substance use treatment for persons with co-occurring disorders.","journal-title":"TIP 42: Substance use treatment for persons with co-occurring disorders"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291722002884"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/19315864.2017.1390712"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1177\/1362361316665222"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1177\/11782218221085599"},{"key":"e_1_3_2_54_1","doi-asserted-by":"crossref","unstructured":"Weir E. Allison C. Baron-Cohen S. (2021). Understanding the substance use of autistic adolescents and adults: A mixed-methods approach. The Lancet Psychiatry 8(8) 673\u2013685. https:\/\/doi.org\/10.1016\/S2215-0366(21)00160-7","DOI":"10.1016\/S2215-0366(21)00160-7"},{"key":"e_1_3_2_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12039"}],"container-title":["Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13623613251325282","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/13623613251325282","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/13623613251325282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:50:30Z","timestamp":1777380630000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/13623613251325282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1177\/13623613251325282"],"URL":"https:\/\/doi.org\/10.1177\/13623613251325282","relation":{},"ISSN":["1362-3613","1461-7005"],"issn-type":[{"value":"1362-3613","type":"print"},{"value":"1461-7005","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]}}}